Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)

Jisun Kim, Woosung Lim, Eun Kyu Kim, Min Kyoon Kim, Nam Sun Paik, Sang Seol Jeong, Jung han Yoon, Chan H. Park, Sei H. Ahn, Lee S. Kim, Sehwan Han, Seok J. Nam, Han Sung Kang, Seung I. Kim, Young B. Yoo, Joon Jeong, Tae H. Kim, Taewoo Kang, Sung Won Kim, Yongsik JungJeong E. Lee, Ku S. Kim, Jong Han Yu, Byung J. Chae, So Youn Jung, Eunyoung Kang, Su Y. Choi, Hyeong Gon Moon, Dong Young Noh, Wonshik Han

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)'. Together they form a unique fingerprint.

Medicine & Life Sciences